Evidence map›Paper›PMID 40520870›Full record

ArticleAmerican journal of cancer research2025

A short-term prognostic model based on urinary IgG, CO

Jiaxiang He, Wei Xiao, Qian Zhao, Cong Lin, Tieying Hou, Zhaohui Sun, Donglin Cao

Abstract read
In one paragraph

Article in American journal of cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jiaxiang HeThe Affiliated Guangdong Second Provincial General Hospital of Jinan University Guangzhou, Guangdong, China.
Wei XiaoThe Affiliated Guangdong Second Provincial General Hospital of Jinan University Guangzhou, Guangdong, China.
Qian ZhaoThe Affiliated Guangdong Second Provincial General Hospital of Jinan University Guangzhou, Guangdong, China.
Cong LinThe Affiliated Guangdong Second Provincial General Hospital of Jinan University Guangzhou, Guangdong, China.
Tieying HouHospital Office, Huazhong University of Science and Technology Union Shenzhen Hospital/Shenzhen Nanshan People's Hospital Shenzhen, Guangdong, China.
Zhaohui SunDepartment of Laboratory Medicine, General Hospital of Southern Theater Command Guangzhou, Guangdong, China.
Donglin CaoThe Affiliated Guangdong Second Provincial General Hospital of Jinan University Guangzhou, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to establish a short-term risk assessment model for patients with newly diagnosed multiple myeloma (NDMM), to augment the current prognosis assessments of MM patients. This model serves as a reference for evaluating the short-term remission of patients. Between January 2013 and March 2023, a total of 232 NDMM patients were enrolled in the Hematology department. The cohort between January 2013 and October 2020 was selected as the training set (n=165) and the cohort between November 2020 and March 2023 was used as the internal validation set (n=67). Using univariate and multivariate forward stepwise Cox analysis, the determined prognostic factors were urinary immunoglobulin G (IgG), carbon dioxide combining power (CO

Indexed as

carbon dioxide combining powerMultiple myelomaprognostic modeltotal proteinurinary immunoglobulin G

Identifiers

PMID40520870
PMCPMC12163450

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.